StatStrip Xpress Glucose Hospital Meter System
Prescription Use Blood Glucose Meter For Near-Patient Testing. 510(k) K182552, from Nova Biomedical Corporation (Walham, MA). Product code PZI, class 2.
As of Nov 18, 2026, K182552 is an FDA 510(k) held by Nova Biomedical Corporation, substantially equivalent on Dec 13, 2018 after 87 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Dec 13, 2018
- Review time: 87 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe StatStrip Xpress Glucose Hospital Meter System is intended for point-of-care, in vitro diagnostic, multiple-patient use for the quantitative determination of glucose in capillary finger stick, venous whole blood, arterial whole blood, neonate arterial whole blood, and neonate heel stick specimens throughout all hospital and all professional healthcare settings, including patients receiving…
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- StatStrip Glucose Hospital Meter SystemK181043 · Nova Biomedical Corporation · Jul 12, 2018
- StatStrip Xpress Glucose Hospital Meter SystemK161856 · Nova Biomedical Corporation · Nov 15, 2016
- StatStrip Xpress Glucose Hospital Meter SystemK150461 · Nova Biomedical Corporation · May 20, 2015
- Nova Statstrip Xpress Glucose Hospital Meter SystemK070960 · Nova Biomedical Corp. · Jul 11, 2007
- The Time Machine Series LasersK152461 · Medical Lasers Manufacturer, Inc. · Jul 8, 2016
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Dual Track
- Received
- Sep 17, 2018
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files